Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TUBA1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IQCJ-SCHIP1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PSMC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAPDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMAGP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL13AP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDOA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
EEF1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIP5K1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PMM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on